This inventor holds 12 USPTO granted patents and 7 published patent applications and 6 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2004-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fairfield, NJ (US) (2004 - 2012)
- Pine Brook, NJ (US) (2012 - 2017)
Company Filing History:
Years Active: 2004-2017
Title: Innovator Spotlight: Nan Jiang of Fairfield, NJ
Introduction
Nan Jiang, an accomplished inventor based in Fairfield, NJ, has made significant strides in the field of pharmaceutical innovations. With a remarkable portfolio of 12 patents, Jiang has dedicated his career to developing solutions that address pressing medical challenges, particularly in the area of antiviral compounds.
Latest Patents
Among his latest contributions, Jiang has focused on antiviral compounds. His innovative work discloses compounds of Formula I, detailed with specific variables, and outlines pharmaceutical compositions that utilize these compounds. The methods described aim to prevent or treat Hepatitis C Virus (HCV) infections, showcasing Jiang's commitment to advancing healthcare through science.
Career Highlights
Jiang currently works with Hoffmann-La Roche Inc., a leading global healthcare company known for its innovative contributions to the pharmaceutical industry. His role within the company has positioned him at the forefront of antiviral research, allowing him to contribute meaningfully to public health.
Collaborations
Throughout his career, Jiang has collaborated with a talented group of researchers, including Qingjie Ding and Xin-Jie Chu. These partnerships highlight the importance of teamwork and shared expertise in the development of groundbreaking pharmaceuticals.
Conclusion
Nan Jiang's contributions to the field of antiviral research and his impressive patent portfolio underscore his role as a significant innovator. As he continues to work on novel pharmaceutical compounds, his efforts are likely to make a lasting impact on the healthcare landscape, providing new hope for those affected by viral infections. His dedication and collaboration in the field serve as an inspiration for future inventors and researchers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
